ERBB2 and liver cancer: Researchers have shown that TGF-β in liver cancer cells, gastric carcinoma cells, and breast cancer cells induces cell apoptosis by activating Caspase-3, inhibiting proteases, increasing Bax protein, and decreasing Bcl-2 protein and the HER-2 /neu gene [16].